Fortis and Gleneagles India deepen collaboration to drive growth
Combined strength of two brands across 11 states to elevate patient care delivery and access to doctors
Combined strength of two brands across 11 states to elevate patient care delivery and access to doctors
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
Aims to support healthcare practitioners with evidence-based cough categorization tools that enable choosing the right molecules for effective & targeted relief from cough
This marks the fourth acquisition by Corona Remedies from multinational corporations
GII is a leading investment firm with assets under management exceeding US$ 3.5 billion with presence across Saudi Arabia, UAE, Europe, USA and India
Finerenone significantly reduced the combined risk of cardiovascular death and total (first and recurrent) heart failure events,
The program will offer a structured and immersive learning experience for over 20,000 healthcare professionals across more than 10 cities
This collaboration marks a significant milestone for Abluva as the company aims to deliver value and innovative solutions in agentic AI security
To streamline complex medical writing workflows with GenAI
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
Subscribe To Our Newsletter & Stay Updated